The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

24 Jan 2023 07:00

RNS Number : 5985N
Norman Broadbent PLC
24 January 2023
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

Trading Update

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, provides the following unaudited trading update for the three months ended 31 December 2022 ("Q4 2022") and the year ended 31 December 2022 ("FY22").

Q4 2022 Highlights

· Group Net Fee Income ("NFI") up 29% to £2.34m (Q4 2021: £1.81m)

· NFI up 40% compared to the average for the previous 3 quarters of £1.67m

· Edinburgh office established ahead of plan to bolster position in Scotland

· Sub-let over capacity in London office with income entirely offsetting cost in 2023 of newly opened Aberdeen and Edinburgh offices

 

FY22 Highlights

· NFI up 27% to £7.34m (FY 2021: £5.8m)

· Positive EBITDA expected to be approximately £100k, up c.£400k on FY 2021's LBITDA of £303k

· Highest expected annual NFI and EBITDA figures since FY 2019 and Company very much back to pre-pandemic levels

· Very positive run rate carry over from Q4 2022 into Q1 2023 with forward contracted revenue up 27% to £1.28m (Q1 2022: £1.01m)

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"I am delighted with our Q4 2022 performance and the achievements of the team in 2022 as a whole. As planned, the Company generated positive annual EBITDA whilst also growing headcount significantly, thus building the platform for continued profitable growth in future years. This includes a number of fee generating hires made in Q4 2022 who will begin delivering revenue in Q1 2023. The quality and seniority of mandates has also been consistently rising over 2022 with the average fee per engagement increasing by 50% over that period. 

There has been significant change across the business over the past 18 months which has been driven and embraced by the entire team. We have very high levels of engagement and collective ambition for the future of Norman Broadbent.

We are aiming to deliver annual EBITDA of £1.25 million in 2025 through organic growth whilst continuing to seek acquisition opportunities. While the economic headwinds remain challenging, I am confident that the necessary foundations are in place to enable us to achieve this target."

For further information please contact:

Norman Broadbent plc

Kevin Davidson, CEO

Mehr Malik, CFO

 

+44 (0) 20 7484 0000

 

Shore Capital (Nominated Adviser and Broker)

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 (0)20 7408 4090

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERLFIVFIV
Date   Source Headline
5th Apr 20117:00 amRNSDirectorate Change
31st Mar 20117:00 amRNSExercise of Warrants
3rd Dec 20107:00 amRNSExpansion into Psychological Assessment Services
15th Sep 20103:48 pmPRNDirector/PDMR Shareholding
14th Sep 201010:45 amPRNResult of General Meeting
14th Sep 20107:00 amRNSInterim Results
27th Aug 20109:47 amPRNPosting of Shareholder Circular
9th Aug 201011:00 amRNSShortage of Non-Executive Directors
28th Jul 20103:40 pmPRNResult of AGM
28th Jul 20107:00 amRNSTrading Update
12th Jul 20107:00 amPRNAdviser - change of name
30th Jun 201010:21 amPRNTotal Voting Rights
29th Jun 20107:01 amRNSDirectorate Changes
29th Jun 20107:00 amRNSFinal Results for the year ended 31 December 2009
15th Jun 20108:05 amRNSNotifiable Interest
14th Jun 201010:23 amRNSResults of General Meeting
14th Jun 20107:00 amRNSJoint Venture with Russam GMS
10th Jun 20105:03 pmPRNHolding(s) in Company
27th May 20107:00 amPRNCapital Reorganisation, Subscription and Change of Name
30th Mar 201010:09 amPRNTrading Statement
16th Mar 20107:00 amPRNChange of Registered Office
29th Jan 20107:00 amPRNTotal Voting Rights
28th Jan 20101:22 pmPRNIssue of Options
22nd Jan 20109:21 amPRNIssue of Equity
7th Jan 201012:17 pmPRNDirector/PDMR Shareholding
23rd Dec 20091:48 pmPRNChange of Adviser
27th Nov 20093:48 pmPRNTrading Statement
30th Sep 20092:09 pmPRNInterim Results
31st Jul 200910:44 amPRNTotal Voting Rights
23rd Jul 20092:59 pmPRNIssue of Equity
22nd Jul 20095:39 pmPRNResult of AGM
26th Jun 20097:30 amPRNFinal Results
31st Dec 20087:00 amRNSTotal Voting Rights
4th Dec 20087:00 amRNSAcquisition and Admission
3rd Dec 20087:53 amRNSCancellation - Garner Plc - Replacement
3rd Dec 20087:00 amRNSUpdate on Acquisition
2nd Dec 20083:46 pmRNSResult of EGM
19th Nov 200811:51 amRNSSchedule 1 - Garner Plc
7th Nov 20083:37 pmPRNAcquisition
30th Sep 20087:00 amPRNHalf-yearly Report
21st May 20084:57 pmPRNResult of AGM
21st May 20084:53 pmPRNLaunch Of HR Practice
30th Apr 20082:27 pmPRNTotal Voting Rights
7th Apr 20081:42 pmPRNAdviser Change of Name
31st Mar 20088:01 amPRNChange of Adviser
31st Mar 20088:00 amPRNFinal Results
20th Dec 200710:38 amPRNDirector Dealing / Grant of Options
22nd Nov 20074:57 pmPRNDirector/PDMR Shareholding
1st Oct 200712:29 pmPRNDirector/PDMR Shareholding
20th Sep 20071:59 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.